In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
What are the common adverse reactions to Gilteritinib fumarate?Common reactions ···【more】
Release date:2026-03-11Recommended:213
What drugs does Gilteritinib Fumarate Tablets interact with?Before taking this m···【more】
Release date:2026-03-11Recommended:196
Use of Gilteritinib Fumarate Tablets with Other MedicationsDuring treatment, doc···【more】
Release date:2026-03-11Recommended:226
Indications and EfficacyThe main component of Gilteritinib Fumarate Tablets is g···【more】
Release date:2026-03-11Recommended:194
During treatment with Selumetinib, in addition to its expected therapeutic effec···【more】
Release date:2026-03-10Recommended:311
August 1, 2017 -- The U.S. Food and Drug Administration today approved Enasideni···【more】
Release date:2026-03-10Recommended:201
During treatment with Enasidenib, in addition to the expected therapeutic effect···【more】
Release date:2026-03-10Recommended:284
On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that sy···【more】
Release date:2026-03-10Recommended:245
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors a···【more】
Release date:2026-03-09Recommended:252
The price of entrectinib fluctuates due to differences in specifications, purcha···【more】
Release date:2026-03-09Recommended:219
The price of entrectinib varies depending on factors such as region, medical ins···【more】
Release date:2026-03-09Recommended:226
Entrectinib is a targeted therapy for solid tumors positive for NTRK gene fusion···【more】
Release date:2026-03-09Recommended:258